UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Encapsulating peritoneal sclerosis and other aspects of long-term peritoneal
dialysis
Vlijm, A.
Publication date
2010
Link to publication
Citation for published version (APA):
Vlijm, A. (2010). Encapsulating peritoneal sclerosis and other aspects of long-term peritoneal
dialysis.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)
and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open
content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please
let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material
inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter
to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You
will be contacted as soon as possible.
15
PUBLICATIES
Vlijm A, Waart de DR, Zweers MM, Krediet RT. Effluent hydroxyproline in experimental peritoneal dialysis. Perit
Dial Int 2007; 27:210-3
Westrhenen van R, Vlijm A, Hiralall JK, Krediet RT. Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solution. Perit Dial Int 2008; 28(Suppl 5):S43-7 Krediet RT, Sampimon DE, Vlijm A, Coester AM, Struijk DG, Smit W. Biological markers in the peritoneal dialysate effluent: are they useful? Contrib Nephrol 2009; 163:54-9
Vlijm A, Stoker J, Bipat S, Spijkerboer AM, Phoa SSKS, Maes R, Struijk DG, Krediet RT. Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2009; 29:517-22 Vlijm A, Phoa SSKS, Noordzij M, Spijkerboer AM, Schuppen van J, Stoker J, Struijk DG, Krediet RT. Are peritoneal calcifications in long-term peritoneal dialysis related to aortic calcifications and disturbances in mineral metabolism? Nephrol Dial Transplant 2010; in press
Graaff de M, Zegwaard AH, Zweers MM, Vlijm A, de Waart DR, Vandemaele F, Struijk DG, Krediet RT. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritonal membrane in chronic renal failure. Perit Dial Int 2010; 30:192-200
Sampimon DE, Korte MR, Lopes Barreto D, Vlijm A, Waart de DR, Struijk DG, Krediet RT. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2010; 30:163-9
Sampimon DE, Vlijm A, Phoa SSKS, Krediet RT, Struijk DG. Encapsulating peritoneal sclerosis in a peritoneal dialysis patients using biocompatible fluids only: is Alport Syndrome a risk factor? Perit Dial Int 2010; 30:240-2 Graaff de M, Vlijm A, Zweers MM, Coester AC, Vandemaele F, Struijk DG, Krediet RT. The addition of a nitric oxide inhibitor to a more biocompatible PD solution in a rat model with chronic renal failure. Advances in Peritoneal
Dialysis 2010; 26: in press
Sampimon DE, Vlijm A, Struijk DG, Krediet RT. Does Alport Syndrome affect the basement membrane of peritoneal vessels? Advances in Peritoneal Dialysis 2010; 26: in press
Sampimon DE, Vlijm A, Struijk DG, Krediet RT. No need for an “expiry date” in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis: comments from around the world. Int Urol Nephrol 2010; 42:248-9 Vlijm A, Sampimon DE, Graaff de M, Struijk DG, Krediet RT. Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore. Nephron Exp Nephrol 2011; 117:e1-8
